MetaCap

Medline Financial Statements

NASDAQ: MDLNHealthcareMedical Instruments & SuppliesUSD

36.26+0.52 (+1.45%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Medline revenue and earnings

In fiscal 2025, Medline generated $28.43 billion in revenue. Net income was $1.16 billion (+0.5% year over year), for a net margin of 4.1% versus a median of 2.8% in the prior 3 years. Gross margin was 26.4% and operating margin 7.8%.

Diluted earnings per share came in at -$0.01. Over the last 3 fiscal years, MDLN's revenue has grown at a 7.0% compound annual rate.

Summary generated from market data by MetaCap's automated system. Methodology

Medline income statement (annual)

Medline annual income statement
Fiscal year (USD)FY 20252025-12-31FY 20252025-12-16FY 20242024-12-31FY 20232023-12-31
Revenue28.43B—25.51B23.23B
Revenue growth (YoY)——+9.80%—
Cost of Revenue20.91B—18.53B17.35B
Gross Profit7.52B—6.98B5.88B
Operating Expenses5.31B—4.83B4.63B
Research & Development80.00M—67.00M60.00M
Selling, General & Admin4.52B—4.11B3.87B
Operating Income2.21B—2.15B1.25B
Interest Expense945.00M—1.14B1.21B
Other Income (Expense)-964.00M—-900.00M-986.00M
Pretax Income1.25B—1.25B264.00M
Income Tax91.00M—46.00M30.00M
Net Income1.16B1.15B1.16B234.00M
Net Income growth (YoY)+0.52%-0.86%+397.01%—
EPS (Basic)-0.01———
EPS (Diluted)-0.01———
Shares Outstanding (Basic)810.00M———
Shares Outstanding (Diluted)810.00M———
EBITDA3.22B—3.12B2.20B
Gross Margin26.44%—27.35%25.33%
Operating Margin7.78%—8.41%5.38%
Net Margin4.08%—4.56%101.00%

This table shows 4 annual periods of Medline's income statement, from FY 2025 back to FY 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow MDLN's reporting calendar. What is a income statement?

More financial data